Cancer’s hiding spots revealed
Discovery that tumor cells can escape from chemotherapy could lead to new treatments that prevent relapse.
Koch Institute
New Koch Institute building to open soon
Researchers will start moving into the 365,000-square-foot building next week.
Surprising similarities between human and zebrafish tumors
New finding that tumor cells in both species have too many chromosomes could help pinpoint genes that drive cancer development.
An unexpected twist in cancer metabolism
A cancer-cell quirk could be exploited to develop new drugs that starve tumors.
A pharmacy on the back of a cell
Drugs encapsulated in new MIT nanoparticles can hitch a ride to tumors on the surface of immune-system cells.
MIT’s Koch Institute in strategic partnership with Ortho-McNeil-Janssen Pharmaceuticals
Organizations will collaborate in multiple areas of oncology research and technology development.
Tackling cancer on a new front
New program at MIT’s Koch Institute targets the growing cancer problem in India.
Rapid analysis of DNA damage now possible
Technology offers a new way to test potential cancer drugs, detect effects of hazardous agents in our environment.
Weighing the cell
MIT biological engineers devise a way to measure, for the first time, how single cells accumulate mass.
To starve a tumor
MIT’s Matthew Vander Heiden is part of a new generation of cancer researchers trying to exploit cancer cells’ strange metabolism.
Explained: RNA interference
Exploiting the recently discovered mechanism could allow biologists to develop disease treatments by shutting down specific genes.
Possible origins of pancreatic cancer revealed
Tumors can arise from different cell types in the pancreas, depending on the circumstances, according to MIT cancer biologists.
Cancer research gets physical
5-year grant from the National Cancer Institute will fund projects by physicists that give a new view of cancer cells.
Protein is linked to lung cancer development
Drugs that inhibit the protein, which normally helps defend cells from infection, could target tumors in certain lung cancer patients.
Two from MIT elected to the Institute of Medicine
Professor of Economics Amy Finkelstein and Tyler Jacks, director of the Koch Institute, join arm of the National Academies of Science.